ES2154285T3 - Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas. - Google Patents

Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas.

Info

Publication number
ES2154285T3
ES2154285T3 ES94401460T ES94401460T ES2154285T3 ES 2154285 T3 ES2154285 T3 ES 2154285T3 ES 94401460 T ES94401460 T ES 94401460T ES 94401460 T ES94401460 T ES 94401460T ES 2154285 T3 ES2154285 T3 ES 2154285T3
Authority
ES
Spain
Prior art keywords
proliferation
beta
derivatives
syntheases
naftoquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94401460T
Other languages
English (en)
Inventor
Christian Bloy
Jean-Pierre Cazenave
Bernard Hercelin
Bernard Teisseire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2154285T3 publication Critical patent/ES2154285T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UTILIZACION DE DERIVADOS DE LA BETA MULA (I): EN LA CUAL R ES UN GRUPO EDICAMENTO QUE PERMITA ACELERAR LA PROLIFERACION DE LAS CELULAS ENDOTELIALES E INHIBIR LAS NO SINTASAS.
ES94401460T 1993-07-02 1994-06-28 Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas. Expired - Lifetime ES2154285T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308111A FR2707494B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
ES2154285T3 true ES2154285T3 (es) 2001-04-01

Family

ID=9448827

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94401460T Expired - Lifetime ES2154285T3 (es) 1993-07-02 1994-06-28 Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas.

Country Status (13)

Country Link
US (1) US5478821A (es)
EP (1) EP0631776B1 (es)
JP (1) JP3993647B2 (es)
AT (1) ATE197668T1 (es)
CA (1) CA2127214C (es)
DE (1) DE69426316T2 (es)
DK (1) DK0631776T3 (es)
ES (1) ES2154285T3 (es)
FR (1) FR2707494B1 (es)
GR (1) GR3035059T3 (es)
HU (1) HU214716B (es)
PT (1) PT631776E (es)
RU (1) RU2131246C1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT758890E (pt) * 1994-05-11 2005-06-30 Jes Olesen Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca
FR2722507B1 (fr) * 1994-07-12 1996-08-14 Rhone Poulenc Rorer Sa Adenovirus comportant un gene codant pour une no synthase
EP0843550A1 (en) * 1995-08-09 1998-05-27 Ontogen Corporation Nitric oxide synthase (nos) inhibitors
WO1998036730A2 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die behandlung von rosacea
IT1312537B1 (it) * 1999-04-16 2002-04-22 Euphar Group Srl Derivati del (-)- verbenone.
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
WO2018156917A1 (en) * 2017-02-23 2018-08-30 The Cleveland Clinic Foundation Anti-aging compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2395638A (en) * 1941-03-07 1946-02-26 Research Corp Hydroxylation of aromatic hydrocarbons
FR924M (es) * 1959-09-26 1961-11-13
US3758520A (en) * 1971-07-23 1973-09-11 C Beaudet Process for the preparation of beta-naphthoquinone semicarbazone
JPH037806A (ja) * 1989-06-05 1991-01-16 Masamoto Kaneko 廃棄物の処理方法及び装置

Also Published As

Publication number Publication date
EP0631776B1 (fr) 2000-11-22
HU9401977D0 (en) 1994-09-28
FR2707494A1 (fr) 1995-01-20
EP0631776A1 (fr) 1995-01-04
DE69426316T2 (de) 2001-05-03
RU2131246C1 (ru) 1999-06-10
RU94022756A (ru) 1996-09-10
HUT70507A (en) 1995-10-30
GR3035059T3 (en) 2001-03-30
DK0631776T3 (da) 2001-03-05
FR2707494B1 (fr) 1995-08-25
HU214716B (hu) 1998-05-28
DE69426316D1 (de) 2000-12-28
JPH07145129A (ja) 1995-06-06
CA2127214C (fr) 2004-10-26
JP3993647B2 (ja) 2007-10-17
PT631776E (pt) 2001-05-31
US5478821A (en) 1995-12-26
ATE197668T1 (de) 2000-12-15
CA2127214A1 (fr) 1995-01-03

Similar Documents

Publication Publication Date Title
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IE891474L (en) Chroman derivatives
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ES2129037T3 (es) Heparosanos-n,o-sulfatados de alta masa molecular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
MX9804416A (es) Diaminopirimidinas, composiciones farmaceuticas que las contienen y su uso como antibacterianos.
ATE197668T1 (de) Verwendung von beta-naphthochinonderivaten zur beschleunigung der proliferation der endothelzellen und inhibierung der no-synthasen
AU1706083A (en) Novel derivatives of guanine i
ES2075180T3 (es) Nuevos derivados de la piridona, su procedimiento de preparacion, los nuevos productos intermedios obtenidos, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
AU644621B2 (en) Pharmaceutical composition for treating or preventing retroviral infections
ES478984A1 (es) Procedimiento de preparacion de productos del grupo de la e-burnamenina.
ES523426A0 (es) Un metodo para preparar nuevos derivados de guanina
SE8005300L (sv) Nya derivat 3,4,5-trimetoxicinnamoylpiperazin, deras framstellning och anvendning som lekemedel
ES2154286T3 (es) Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria.
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
ES2149247T3 (es) Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen.
DE69430074D1 (de) Analgetische 4-arylisoindolen
IL92402A0 (en) Pyrimidine nucleoside derivatives,their preparation and pharmaceutical compositions containing them
SE8804037D0 (sv) Nya 4-demetoxiantracyclinderivat
DE3780080D1 (de) Coccidiozide mittel.
DE3851936D1 (de) Ester vom Etretintyp und ähnliche Ester von makroliden Antibiotika und linkosamide Antibiotika, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen und kosmetischen Zusammensetzungen.
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d&#39;addition et composition pharmaceutique utilisant ces produits
BE891048A (fr) Dihydro-4&#39;, 5&#39; antibiotique ax-127b-1, n-des-beta-lysyl-2&#39; dihydro-4&#39;, 5&#39; antibiotique ax-127b-1, leurs derives n-acyl-4 et n-alkyl-4 et leurs sels acceptables en pharmacie, utiles comme intermediaires pour la preparation des derives 0-demethyl-3 correspondants de l&#39;antibiotique ax-127b-1 et comme medicaments antibiotiques

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 631776

Country of ref document: ES